FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

9 letters match. Newest first.

  1. Sciarra Aeromed, Inc.

    Sciarra Aeromed's purportedly sterile veterinary drug was contaminated and made under insanitary conditions, FDA says.

    High risk
  2. ABS Corporation

    ABS Corporation released out-of-specification veterinary drugs and used inadequately tested raw materials, FDA says.

    High risk
  3. Elanco Animal Health USA

    FDA says Elanco's Pradalex ads misbrand the livestock antibiotic by claiming first-line use and "all relevant pathogen" coverage.

    Medium
  4. Aurora Pharmaceutical

    FDA told Aurora Pharmaceutical its websites and brochures for three animal drugs hid safety warnings, making the products misbranded.

    Medium
  5. Nutrition Strength Ltd.

    FDA warns Nutrition Strength Ltd. over unapproved dog seizure and blood-support supplements marketed as animal drugs.

    High risk
  6. totaltoltrazuril.com

    FDA warned totaltoltrazuril.com for selling Total Toltrazuril, an unapproved new animal drug, for coccidiosis and horse EPM.

    High risk
  7. Boehringer Ingelheim Animal Health USA

    FDA warned Boehringer Ingelheim Animal Health USA that Senvelgo promotional materials falsely claimed safety and effectiveness in previously insulin-treated cats.

    High risk
  8. Equine Podiatry Solutions, LLC

    Equine Podiatry Solutions marketed Desmosphyrine, an unapproved new animal drug, for treating laminitis in horses.

    High risk
  9. Groupe Cyrenne Inc. dba HomeoAnimal

    FDA warned HomeoAnimal that it sells unapproved animal drugs with claims to treat cancer, heartworm, seizures, and COVID-19 in animals.

    High risk